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A B S T R A C T
Conventional pancreatoduodenectomy (PD) for bile duct and papilla carcinoma is associated with a risk
of surgical site infection and peritoneal tumor seeding because of the timing of bile duct removal. In our
modiﬁed PD procedure, transection of the ligament of Treitz was performed, followed by resection of
the jejunum and duodenum. Pancreatic tunneling was performed from the caudal side. Finally, the tumor
was removed by cutting the bile duct. To prevent bile exposure, all anastomoses other than
choledochojejunostomy were performed before bile duct removal. We retrospectively compared the ef-
fectiveness of our modiﬁed PD technique by comparing data from seven patients who underwent modiﬁed
PD with 19 patients who underwent conventional PD. The rate of surgical site infection was 28.6% in
the modiﬁed PD group and 73.6% in the conventional PD group (P = 0.04). The cumulative and recurrence-
free survival rates were not signiﬁcantly different between the two groups. Thus, modiﬁed PDmay reduce
the risk of surgical site infection.We conclude thatmodiﬁed PDmay reduce the risk of surgical site infection.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Pancreatoduodenectomy (PD) is the generally accepted surgi-
cal treatment for bile duct carcinoma and papilla carcinoma. In the
conventional approach to PD, the bile duct is removed at an early
stage in the operation, prior to resection of the pancreas. Using this
approach, however, the undesirable event of bile dischargemay occur
during the operation, posing a risk of tumor seeding and/or surgi-
cal site infection. In particular, in patients with bile duct carcinoma
and papilla carcinoma, which are sometimes detected because of
the presence of obstructive jaundice, bile aspirated through the pre-
operative biliary drainage route may often contain cancer cells.
Even if the bile duct is clamped during PD, a certain amount of
bile leakage from the cut end of the duct is unavoidable. There-
fore, wemodiﬁed the PD procedure to prevent intraoperative release
of bile into the surgical site. In this modiﬁed method, the bile duct
is cut at the very end of the operation. We herein present our ex-
perience with this modiﬁed PD method.
2. Presentation of case
The patients were placed in the supine position under general
anesthesia, and a median or J-shaped incision was made. The ﬁrst
step was to check for peritoneal dissemination or liver metastasis,
and the second was to determine whether the main tumor was re-
sectable; if it was resectable, the duodenumwas mobilized and the
ligament of Treitz was transected. The jejunum was cut, preserv-
ing the jejunal artery. Tunneling behind the pancreatic head was
performed from the caudal side. We consider it preferable to cut
the duodenum and gastroduodenal artery before removing the pan-
creatic head. The pancreatic head was then resected using an
electrosurgical knife or ultrasonically activated coagulating shears.
The hepatic, celiac, right superior pancreatic, and right superior mes-
enteric lymph nodes were removed. At this point, the tumor was
only connected to the bile duct. Gastrojejunostomy, jejunojejunos-
tomy, and pancreaticogastrostomy were performed before the bile
duct was removed (Fig. 1). The procedure was similarly per-
formed in cases in which the pancreas and jejunum were
anastomosed. Finally, choledochojejunostomy was performed after
the tumor was removed.
3. Discussion
PD is usually performed for pancreatic head carcinoma, extra-
hepatic bile duct carcinoma, and papilla carcinoma. Generally, the
operating time is long and the rate of complications is high. The re-
ported PD-related morbidity rate is 49.6% [1], and the reported PD-
related mortality rate in elderly patients is 6.3% [2]. Surgical site
infection is one of the main complications of concern and may be
induced by bile leakage; exposure of the operative ﬁeld to bile-
containing bacteria may impose a risk of surgical site infection.
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Therefore, patients who present with obstructive jaundice associ-
ated with bile duct inﬂammation are often preoperatively examined
for signs of infected bile.
Another risk associated with intraoperative bile leakage is pos-
sible tumor seeding following percutaneous transhepatic biliary
drainage (PTBD) for extrahepatic bile duct carcinoma or papilla car-
cinoma because the bile may contain cancer cells. A previous study
reported that the rate of tumor seeding after PTBDwas 6% [3], while
another reported that in patients found to have tumor seeding during
the operation, the PTBD tube had been in place for a mean period
of 8 days before the operation [4].
During conventional PD, the bile duct is cut early in the opera-
tion, followed by resection of the pancreatic head, tumor removal,
and anastomosis including choledochojejunostomy. While all these
procedures are being performed, the cut end of the bile duct is
exposed, and the bile is released into the surgical site even if biliary
drainage is employed. In a previous study, 10 patients with preop-
erative positive bile cytology were all found to be positive by
intraoperative positive bile cytology [5], suggesting the risk of peri-
toneal seeding due to inadvertent leakage of bile into the surgical
site. Although studies have reported some cases of long-term sur-
vival after complete resection of the seeding [6–9], seeding remains
a factor associated with a poor prognosis, as suggested by a study
that found a 4-year cumulative survival rate of 27% for patients in
whom resection was performed for biliary drainage catheter tract
seeding [10]. Therefore, to prevent bile spillage, we modiﬁed the
conventional PD procedure such that the bile duct was cut at the
very end of the operation, just before the choledochojejunostomy.
We examined the effectiveness of the modiﬁed PD by compar-
ing 7 patients who underwent this novel procedure with 19 patients
who underwent conventional PD from April 2005 to the end of Feb-
ruary 2012. All patients had extrahepatic bile duct carcinoma or
papilla carcinoma. We compared the patients’ backgrounds, tumor
locations, preoperative tumor marker concentrations, tumor dif-
ferentiation, presence or absence of lymph node metastasis, disease
stage (Japanese classiﬁcation), preoperative bile cytology, intraop-
erative bleeding, duration of hospital stay, rate of morbidity, rate
of surgical site infection, cumulative survival rate, and recurrence-
free survival rate between modiﬁed and conventional PDs.
All statistical analyses were performed using the statistical soft-
ware JMP 9.0.2 (Macintosh; SAS Institute, Japan). Categorical variables
and numerical variables were analyzed using Fisher’s exact test and
the Mann–Whitney U test, respectively. Overall survival was
calculated from the date of operation to the date of death.
Recurrence-free survival was determined from the date of opera-
tion to the date of recurrence. The overall survival and recurrence-
free survival rates were estimated using the Kaplan–Meier method
Fig. 1. Pancreaticogastrostomy, gastrojejunostomy, and jejunojejunostomywere per-
formed before cutting of the bile duct.
Fig. 2. Cumulative survival rates (P = 0.15) and recurrence-free survival rates (P = 0.13) of modiﬁed and conventional pancreatoduodenectomy.
Table 1
Laboratory data and postoperative course of each group.
Modiﬁed
PD (n = 7)
Conventional
PD (n = 19)
P value
Age (years) 64 ± 11 65 ± 10 0.36
Sex (male/female) 4/3 10/9 0.83
Location (Bm/Bi/Vater) 2/4/1 4/5/10 0.19
CEA (ng/ml) 3.7 ± 1.9 5.7 ± 7.4 0.56
CA19-9 (U/ml) 134 ± 133 164 ± 327 0.34
Pathology (well/mod/poor/other) 6/0/0/1 10/5/2/2 0.31
Lymph node metastasis (+/−) 6/1 10/9 0.12
Disease stage (I/II/III/IV) 0/0/4/3 4/5/1/9 0.01
Bile cytology (class I/II/III/IV/V) 1/0/0/0/0 1/0/2/0/2 Incomputable
Intraoperative bleeding (ml) 982 ± 459 866 ± 520 0.55
Operative duration (min) 452 ± 112 458 ± 57 0.61
Hospital stay (days) 43 ± 22 47 ± 34 1.00
Morbidity (SSI/other) 2/1 14/1 0.38
Rate of SSI (%) 28.6 73.6 0.04
Bm: middle part of main bile duct, Bi: inferior part of main bile duct, Vater: ampulla
of Vater, CEA: carcinoembryonic antigen, CA19-9: carbohydrate antigen 19-9, Well:
well-differentiated adenocarcinoma, Mod: moderately differentiated adenocarci-
noma, Poor: poorly differentiated adenocarcinoma, SSI: surgical site infection.
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and compared between the two groups using the log rank test. A
P value of <0.05 was considered statistically signiﬁcant.
The background data of the groups are presented in Table 1. No
signiﬁcant differences in any parameter except disease stage were
found between the groups. The modiﬁed PD group had a signiﬁ-
cantly larger number of patients with advanced cancer than did the
conventional PD group. All patients in the modiﬁed PD group had
stage III or IV cancer, while only 10 of the 19 patients (52.6%) in
the conventional PD group had stage III or IV cancer (P = 0.01).
Fig. 2 shows the cumulative survival rates and recurrence-free
survival rates of the two groups. The 1- and 3-year cumulative sur-
vival rates in the modiﬁed PD group were 75% and 50%, respectively,
while those in the conventional PD group were 83% and 59%, re-
spectively. No signiﬁcant between-group difference in these values
was seen (P = 0.15). The 1- and 3-year recurrence-free survival rates
in the modiﬁed PD group were 25% and 0%, respectively, while those
in the conventional PD group were 55% and 50%, respectively. No
signiﬁcant between-group difference in these values was seen
(P = 0.13).
Although we found no signiﬁcant difference in the cumulative
or recurrence-free survival rates between the groups, there was a
likelihood of poorer prognosis in the modiﬁed PD group than in
the conventional PD group because the modiﬁed PD group in-
cludedmore patients with advanced-stage cancer. Notably, however,
the incidence of surgical site infection was 28.6% and 73.6% in the
modiﬁed and conventional PD groups, respectively. A signiﬁcant
difference was found in the incidence of surgical site infection
between the groups (P = 0.04) (Table 1). Furthermore, no signiﬁ-
cant differences were found in the operative time or amount of
intraoperative bleeding. However, the results indicated the possi-
bility that the modiﬁed PDmethodmight reduce the risk of surgical
site infection.
4. Conclusion
Based on the above ﬁndings, we concluded that the modiﬁed PD
procedure has the potential to reduce the incidence of surgical site
infection and thus may be considered as a safer procedure with
which to treat bile duct carcinoma and papilla carcinoma.
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